STEMCENTRX
Stemcentrx develops therapies that cure and significantly improve survival for cancer patients. It provides disease specific treatments that attack tumors at the roots. Brian Slingerland and Scott J. Dylla founded Stemcentrx in 2008, with its headquarters in South San Francisco in California. Stemcentrx operates as a subsidiary of AbbVie as of June 1, 2016.
STEMCENTRX
Industry:
Alternative Medicine Biotechnology Health Diagnostics Pharmaceutical Therapeutics
Founded:
2008-01-01
Address:
South San Francisco, California, United States
Country:
United States
Website Url:
http://www.stemcentrx.com
Total Employee:
101+
Status:
Active
Contact:
16504910116
Email Addresses:
[email protected]
Total Funding:
515.53 M USD
Technology used in webpage:
Domain Not Resolving SPF Google Maps Google Apps For Business GStatic Google Static Content Google Maps API Microsoft Azure DNS GoDaddy
Similar Organizations
Accent Therapeutics
Accent Therapeutics is a biopharmaceutical company.
Aclaris Therapeutics
Aclaris Therapeutics is a specialty pharmaceutical company engaged in developing dermatologic therapies.
Cobra Biologics
Cobra Biologics is providing a biologics and pharmaceuticals service.
Guardian Pharmacy
Guardian Pharmacy is a pharmacy company provide outstanding client service to long-term care facilities.
Indiva
Indiva provide access to medical cannabis.
Labcyte
Labcyte is the maker of Echo Acoustic Liquid Handling systems for life sciences.
Malladi Drugs
Malladi Drugs is a pharmaceutical manufacturing company manufacturing medicines.
Nymox Pharmaceutical
Nymox Pharmaceutical is a biopharmaceutical company.
Pliant Therapeutics
Pliant Therapeutics focuses on discovering, developing, and commercializing breakthrough treatments for fibrotic diseases.
TruTag Technologies
TruTag Technologies, Inc. provides product authentication and brand protection solutions.
Current Advisors List
Founder
Investors List
Sequoia Capital
Sequoia Capital investment in Series G - Stemcentrx
Artis Ventures (AV)
Artis Ventures (AV) investment in Series G - Stemcentrx
Fidelity
Fidelity investment in Series G - Stemcentrx
Founders Fund
Founders Fund investment in Series G - Stemcentrx
Silicon Valley Bank
Silicon Valley Bank investment in Series G - Stemcentrx
Oakhouse Partners
Oakhouse Partners investment in Series G - Stemcentrx
Sequoia Capital
Sequoia Capital investment in Series F - Stemcentrx
Capital Group
Capital Group investment in Series F - Stemcentrx
Artis Ventures (AV)
Artis Ventures (AV) investment in Series F - Stemcentrx
Founders Fund
Founders Fund investment in Series F - Stemcentrx
Official Site Inspections
http://www.stemcentrx.com
- Host name: p3nlhg216c1216.shr.prod.phx3.secureserver.net
- IP address: 184.168.177.1
- Location: Scottsdale United States
- Latitude: 33.6013
- Longitude: -111.8867
- Metro Code: 753
- Timezone: America/Phoenix
- Postal: 85260
More informations about "Stemcentrx"
Stemcentrx - Crunchbase Company Profile & Funding
Stemcentrx develops therapies that cure and significantly improve survival for cancer patients. It provides disease specific treatments that attack tumors at the roots. Brian Slingerland and Scott J. Dylla founded Stemcentrx in 2008, with …See details»
StemCentRx Company Profile - Office Locations, Competitors
StemCentRx is a company that provides pharmaceutical services. It develops therapies that cure and significantly improve survival for cancer patients. The company provides disease-specific …See details»
Stemcentrx Company Profile 2024: Valuation, …
Stemcentrx General Information Description. Provider of cancer research and drug-development services designed to find a new approach to treat cancer. The company's services provide therapies to eliminate cancer stem cells, which …See details»
This Startup That's Trying to Cure Cancer Just Got …
Apr 28, 2016 The Stemcentrx drug that’s farthest along thus far is called rovalpitzumab tesirine, or Rova-T. It’s currently in phase 1 trials to treat small …See details»
Stemcentrx, Inc. - LinkedIn
Stemcentrx, Inc. | 5,296 followers on LinkedIn. Founded in 2008, Stemcentrx combines state-of-the-art research and GMP manufacturing capabilities. This has allowed us to advance from …See details»
Stemcentrx Company Profile: Overview and Full News Analysis
Stemcentrx's products and services revolve around precision medicine and personalized therapies, aiming to revolutionize the way cancer is treated by identifying and targeting the …See details»
AbbVie to Expand Oncology Presence Through Acquisition of …
NORTH CHICAGO, Ill., April 28, 2016 /PRNewswire/ -- AbbVie (NYSE:ABBV), a global biopharmaceutical company, announced that it will acquire Stemcentrx and its lead late-stage …See details»
StemCentRx - VentureRadar
Stemcentrx develops therapies that aim to cure and significantly improve survival for cancer patients. They are pioneering new approaches to eliminate cancer stem cells, which initiate …See details»
AbbVie buys Stemcentrx for $5.8 billion, builds cancer drug offerings
Apr 28, 2016 AbbVie announced Thursday it is acquiring privately held Stemcentrx for $5.8 billion in cash and stock, with additional milestone guarantees of up to $4 billion. The purchase …See details»
Stemcentrx, Inc. Company Information - Funding, Investors, and …
Stemcentrx, Inc. is a South San Francisco, California-based company founded in 2008.See details»
AbbVie to acquire Stemcentrx in $5.8bn deal - Financial Times
Apr 28, 2016 The Illinois-based company lowered its 2016 earnings forecast to between $4.62 to $4.82 per share, reflecting the Stemcentrx acquisition, down from its previous estimates for …See details»
Why AbbVie Acquired Stemcentrx - Business Insider
Apr 28, 2016 AbbVie, a major biopharmaceutical company, just picked up biotech startup Stemcentrx in a deal that's worth up to $10.2 billion. That would make it the second-largest …See details»
Stemcentrx bags $5.8 billion, even as Notch agent underwhelms
Jul 12, 2016 Stemcentrx showed that in a phase 1 trial of 74 patients with SCLC, 18% achieved either a complete response or a partial response with median overall survival at 4.6 months. In …See details»
AbbVie bags a unicorn with $9.8B buyout deal for Stemcentrx
Apr 28, 2016 The pharma company put weeks of market buzz to rest today with the news that it is buying Stemcentrx, the little-known South San Francisco-based biotech pursuing a trendy …See details»
Stemcentrx - Tech Stack, Apps, Patents & Trademarks - Crunchbase
Organization. Stemcentrx . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Total Products Active 7. ... Stemcentrx has …See details»
Stemcentrx - Contacts, Employees, Board Members, Advisors
Organization. Stemcentrx . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Number of Board Member and Advisor …See details»
Brian Slingerland - Link Cell Therapies
Brian Slingerland co-founded and was the CEO of Stemcentrx, which discovered a number of novel cancer targets and developed in-house target validation, GMP manufacturing and …See details»
Stemcentrx and the New Startup Dispersion — The Information
Apr 29, 2016 Yesterday was an M&A bonanza with some $50 billion in deals announced, led by pharma and rounded out by Comcast’s acquisition of DreamWorks Animation. But the deal …See details»
The Last of Stemcentrx - Science | AAAS
Aug 30, 2019 Welcome to biotech, then. We're a long way from 1, and for a lot of good reasons. If by "success" you mean unloading the company for a very large payout, then Stemcentrx …See details»
Stemcentrx Reviews: What Is It Like to Work At Stemcentrx?
11 Stemcentrx reviews. A free inside look at company reviews and salaries posted anonymously by employees.See details»